James E Herndon Selected Research

Paclitaxel (Taxol)

11/2008	Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430.
11/2008	Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
2/2008	Phase II trial of weekly dose-dense paclitaxel in extensive-stage small cell lung cancer: cancer and leukemia group B study 39901.
7/2005	Induction paclitaxel/carboplatin followed by concurrent chemoradiation therapy for unresectable stage III non-small-cell lung cancer: a limited-access study--CALGB 9534.
6/2005	Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732.
11/2004	Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium.
5/2003	Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B.
10/2002	Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431.
2/2002	Novel doublets in extensive-stage small-cell lung cancer: a randomized phase II study of topotecan plus cisplatin or paclitaxel (CALGB 9430).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James E Herndon Research Topics

Disease

121	Neoplasms (Cancer) 01/2024 - 01/2002
60	Glioma (Gliomas) 01/2023 - 03/2002
52	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2004
26	Leukemia 09/2019 - 01/2002
20	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 01/2002
19	Brain Neoplasms (Brain Tumor) 01/2022 - 10/2003
16	Breast Neoplasms (Breast Cancer) 12/2023 - 08/2003
12	Lung Neoplasms (Lung Cancer) 01/2023 - 06/2004
11	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2008 - 02/2002
9	Fatigue 04/2022 - 10/2010
8	Chronic Disease (Chronic Diseases) 04/2022 - 12/2008
7	Neoplasm Metastasis (Metastasis) 01/2023 - 03/2002
6	Nausea 12/2020 - 03/2008
6	Vomiting 12/2020 - 03/2008
6	Lymphopenia (Lymphocytopenia) 01/2018 - 03/2011
6	Dyspnea (Shortness of Breath) 10/2015 - 04/2005
5	Melanoma (Melanoma, Malignant) 01/2013 - 04/2006
4	Disease Progression 04/2019 - 07/2002
4	Diarrhea 07/2012 - 01/2004
4	Hypoxia (Hypoxemia) 04/2011 - 01/2008
4	Weight Loss (Weight Reduction) 09/2009 - 01/2006
4	Neutropenia 06/2009 - 01/2006
3	Necrosis 01/2024 - 10/2017
3	Infections 01/2023 - 03/2008
3	Medulloblastoma 01/2023 - 12/2004
3	Meningioma (Meningiomas) 05/2022 - 01/2012
3	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 01/2006
3	Thrombocytopenia (Thrombopenia) 03/2012 - 10/2002
3	Carcinogenesis 09/2011 - 04/2005
3	Colorectal Neoplasms (Colorectal Cancer) 01/2010 - 03/2006
3	Febrile Neutropenia 06/2009 - 01/2006
3	Malignant Mesothelioma 06/2005 - 05/2004
3	Carcinoma (Carcinomatosis) 11/2004 - 01/2002
2	Inflammation (Inflammations) 01/2023 - 12/2018
2	Poliomyelitis (Polio) 01/2023 - 01/2021
2	Lymphoma (Lymphomas) 04/2020 - 08/2013
2	Residual Neoplasm 09/2018 - 11/2010

Drug/Important Bio-Agent (IBA)

30	Temozolomide (Temodar)FDA LinkGeneric 12/2020 - 02/2003
24	Bevacizumab (Avastin)FDA Link 01/2023 - 02/2007
20	Irinotecan (Camptosar)FDA LinkGeneric 04/2019 - 04/2004
19	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2004
17	epidermal growth factor receptor VIIIIBA 01/2023 - 01/2008
11	VaccinesIBA 10/2020 - 11/2008
11	AntigensIBA 01/2018 - 04/2006
11	Monoclonal AntibodiesIBA 08/2012 - 03/2002
9	Carboplatin (JM8)FDA LinkGeneric 03/2012 - 07/2002
9	Paclitaxel (Taxol)FDA LinkGeneric 11/2008 - 02/2002
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2004
7	Cisplatin (Platino)FDA LinkGeneric 11/2008 - 01/2002
6	Biomarkers (Surrogate Marker)IBA 04/2015 - 12/2004
6	Imatinib Mesylate (Gleevec)FDA Link 10/2012 - 12/2005
6	Tyrosine Kinase InhibitorsIBA 07/2012 - 01/2004
6	O(6)-benzylguanineIBA 10/2009 - 05/2002
5	Messenger RNA (mRNA)IBA 01/2023 - 03/2002
5	Chimeric Antigen ReceptorsIBA 01/2019 - 01/2014
5	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2012 - 12/2005
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2012 - 01/2008
4	7- chloro- 8- hydroxy- 1- (3'- iodophenyl)- 3- methyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepine (TISCH)IBA 06/2021 - 07/2014
4	AntiemeticsIBA 05/2020 - 07/2014
4	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2014 - 02/2004
4	Immunotoxins (Immunotoxin)IBA 07/2011 - 01/2008
4	Etoposide (VP 16)FDA LinkGeneric 06/2011 - 02/2005
4	Carmustine (FIVB)FDA Link 08/2009 - 05/2002
4	Vinorelbine (Navelbine)FDA LinkGeneric 06/2007 - 10/2002
3	Ondansetron (Zofran)FDA LinkGeneric 12/2020 - 01/2017
3	Dasatinib (BMS 354825)FDA Link 01/2020 - 07/2012
3	Adenosine Triphosphate (ATP)IBA 01/2020 - 12/2005
3	EnzymesIBA 01/2019 - 04/2005
3	MethyltransferasesIBA 01/2019 - 10/2005
3	Palonosetron (Aloxi)FDA Link 01/2017 - 07/2014
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2012 - 01/2010
3	O(6)-Methylguanine-DNA MethyltransferaseIBA 12/2009 - 05/2002
3	TabletsIBA 06/2009 - 12/2008
3	Gefitinib (Iressa)FDA Link 02/2006 - 01/2004
3	Topoisomerase I InhibitorsIBA 10/2005 - 04/2004
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2023 - 03/2005
2	RNA (Ribonucleic Acid)IBA 01/2023 - 03/2015
2	Phosphotransferases (Kinase)IBA 01/2023 - 06/2008
2	poliovirus receptorIBA 01/2023 - 12/2018
2	Aprepitant (Emend)FDA Link 12/2020 - 05/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 07/2014
2	Interleukin-2 (IL2)IBA 01/2019 - 01/2012
2	Vorinostat FDA Link 04/2018 - 01/2018
2	Single-Chain AntibodiesIBA 01/2018 - 07/2011
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2018 - 03/2014
2	Oxygen (Dioxygen)IBA 10/2015 - 09/2010
2	Clostridium perfringens epsilon-toxinIBA 02/2015 - 01/2014
2	Alkylating AgentsIBA 08/2013 - 01/2013

Therapy/Procedure

72	Therapeutics 01/2024 - 01/2002
43	Drug Therapy (Chemotherapy) 12/2023 - 01/2002
26	Radiotherapy 05/2022 - 10/2002
15	Immunotherapy 01/2023 - 11/2008
6	Induction Chemotherapy 09/2009 - 10/2002
5	Adjuvant Chemotherapy 12/2023 - 08/2003
5	Catheters 01/2023 - 07/2002
5	Salvage Therapy 05/2022 - 09/2004
4	Chemoradiotherapy 01/2011 - 10/2002
3	Lasers (Laser) 01/2024 - 01/2022
3	Exercise Therapy (Therapy, Exercise) 12/2023 - 01/2020
3	Aftercare (After-Treatment) 10/2017 - 08/2003